The Cost of Diabetes Type II in Europe The CODE-2 Study (original) (raw)

Article PDF

Abbreviations

CODE:

Cost of Diabetes in Europe

UKPDS:

United Kingdom Prospective Diabetes Study

References

  1. Zimmet PZ (1999) Diabetes epidemiology as a tool to trigger diabetes research and care. Diabetologia 42:499–518
    Article CAS PubMed Google Scholar
  2. King H, Aubert RE, Herman WH (1998) Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 21:1414–1431
    Article CAS PubMed Google Scholar
  3. Zimmet P, McCarty D (1995) The NIDDM epidemic: global estimates and projections — a look into the crystal ball. IDF Bulletin 40:8–16 (OK)
    Google Scholar
  4. Nijpels G, Popp-Snijders C, Kostense PJ et al. (1997) Car-diovascular risk factors prior to the development of non-insulin-dependent diabetes mellitus in persons with impaired glucose tolerance: the Hoorn Study. J Clin Epidemiol 50:1003–1009
    Article CAS PubMed Google Scholar
  5. Haffner SM, Stern MP, Hazuda HP et al. (1990) Cardiovascular risk factors in confirmed prediabetic individuals. JAMA 263:2893–2898
    Article CAS PubMed Google Scholar
  6. Haffner SM, D’Agostino R, Mykkanen L et al. (1999) Insulin sensitivity in subjects with Type 2 diabetes. Diabetes Care 22:562–568
    Article CAS PubMed Google Scholar
  7. Haffner SM, Lehto S, Ronnemaa T et al. (1998): Mortality from coronary heart disease in subjects with Type 2 diabetes and in non-diabetic subjects with and without myocardial infarction. N Engl J Med 399:229–2348
    Article Google Scholar
  8. The hypertension in Diabetes Study Group (1993) Hypertension in Diabetes Study (HDS): II. Increased risk of cardiovascular complications in hypertensive Type 2 diabetic patients. J Hypertens 11:319–325
    Article Google Scholar
  9. Alberti KGMM, Griess FA, Jervell J, Krans HMJ, for the European NIDDM Policy Group (1994) A desktop guide for the management of non-insulin-dependent diabetes mellitus (NIDDM): an update. Diabet Med 11:899–909
    Article CAS PubMed Google Scholar
  10. UK prospective Diabetes Study Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with Type 2 diabetes (UKPDS 33). Lancet 352:837–853
    Article Google Scholar
  11. UK prospective Diabetes Study Group (1998) Intensive blood-glucose control with metformin on complications in overweight patients with Type 2 diabetes (UKPDS 33). Lancet 352:854–865
    Article Google Scholar
  12. UK prospective Diabetes Study Group (1998) Tight blood pressure control and risk of macrovascular and microvascular complications in Type 2 diabetes (UKPDS 33). BMJ 352:703–713
    Article Google Scholar
  13. UK prospective Diabetes Study Group (1998) Efficacy of atenolol and Captopril in reducing risk of both macrovascular and microvascular complications in Type 2 diabetes (UKPDS 39). BMJ 317:713–720
    Article PubMed Central Google Scholar
  14. O’Brien JA, Shomphe LA, Kavanagh PL, Raggio G, Caro JJ (1998) Direct medical costs of complications resulting from Type 2 diabetes in the US. Diabetes Care 21:1122–1128
    Article PubMed Google Scholar
  15. Brown JB, Pedula KL, Bakst AW (1999) The progressive cost of complications in Type 2 diabetes mellitus. Arch Intern Med 159:1873–1880
    Article CAS PubMed Google Scholar
  16. Nicolucci A, Cavalière D, Scorpiglione N et al. (1996) A comprehensive assessment of the avoidability of long term complications of diabetes mellitus: a case-control study. Diabetes Care 19:927–933
    Article CAS PubMed Google Scholar
  17. Bray GA, Culbert IW, Champagne CM et al. (2000) The Diabetes Prevention Program-Baseline characteristics of the randomised cohort. Diabetes Care 23:1619–1629
    Article Google Scholar
  18. Chiasson JL, Gomis R, Hanefeld M, Josse RG, Karasik A, Laakso M (1998) The STOP-NIDDM Trial: an international study of the efficacy of an alpha-glucosidase inhibitor to prevent Type 2 diabetes in a population with impaired glucose tolerance: rationale, design, and preliminary screening data. Study to prevent Non-insulin-Dependent Diabetes Mellitus. Diabetes Care 21:1720–1725
    Article CAS PubMed Google Scholar
  19. Ratner RE (1998) Type 2 diabetes mellitus: the grand overview. Diabet Med 15 [Suppl 4]:S4–S7
    Article PubMed Google Scholar
  20. American Diabetic Association (1998) Economic consequences of Diabetes Mellitus in the U.S. in 1997. Diabetes Care 21:296–309
    Article Google Scholar

Download references

Author information

Authors and Affiliations

  1. Dipartimento di Medicina Interna, Università di Perugia, Via E. dal Pozzo, 06126, Perugia, Italy
    M. Massi-Benedetti

Authors

  1. M. Massi-Benedetti
    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence toM. Massi-Benedetti.

Additional information

M. Massi-Benedetti wrote on behalf of the CODE-2 Advisory Board

Rights and permissions

About this article

Cite this article

Massi-Benedetti, M. The Cost of Diabetes Type II in Europe The CODE-2 Study.Diabetologia 45 (Suppl 1), S1–S4 (2002). https://doi.org/10.1007/s00125-002-0860-3

Download citation